Related Experiment Video
Updated: Dec 24, 2025
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
6.4K
RAF kinase dimerization: implications for drug discovery and clinical outcomes
Tilman Brummer1,2,3, Campbell McInnes4
1Institute of Molecular Medicine and Cell Research, Faculty of Medicine, University of Freiburg, Stefan-Meier-Strasse 17, 79104, Freiburg im Breisgau, Germany.
Oncogene
|April 10, 2020
Summary
RAF kinase dimerization is crucial for cell signaling and drug resistance in cancers like melanoma. Targeting these RAF dimers offers new therapeutic strategies beyond traditional inhibitors.
Area of Science:
- Molecular biology and cancer therapeutics
- Signal transduction pathways
- Kinase inhibitor development
Background:
- RAS GTPases activate RAF kinases, regulating cell growth via the ERK cascade.
- Mutations in RAF, RAS, and receptor tyrosine kinases drive tumor formation.
- First-generation RAF inhibitors showed promise but faced drug resistance.
Purpose of the Study:
- To review the role of RAF kinase dimerization in signal transduction and cancer.
- To discuss implications of RAF dimerization for drug development and resistance.
- To explore novel therapeutic strategies targeting RAF dimer formation.
Main Methods:
- Review of existing literature on RAF kinase signaling and dimerization.
- Analysis of structural data of the RAF dimer interface (DIF).
- Discussion of structure-based drug design for next-generation inhibitors.
Main Results:
- RAF dimerization (homo- and hetero-dimerization) is a critical step in RAF signaling.
- Dimerization significantly impacts the efficacy of ATP-competitive RAF inhibitors.
- RAF dimerization plays a key role in both intrinsic and acquired drug resistance.
Conclusions:
- Understanding RAF dimerization is essential for overcoming therapeutic resistance.
- Inhibiting RAF dimer formation presents a promising new therapeutic strategy.
- DIF inhibitors may be effective for various cancers, including those with non-V600E BRAF mutations and fusions.
Related Concept Videos
01:26Receptor Tyrosine Kinases
17.5K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
17.5K
01:22PI3K/mTOR/AKT Signaling Pathway
5.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.1K
01:27Transducer Mechanism: Enzyme-Linked Receptors
3.7K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.7K
01:07MAPK Signaling Cascades
7.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K
01:22Amplifying Signals via Enzymatic Cascade
16.7K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.7K
01:19Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K